211 related articles for article (PubMed ID: 27922807)
1. Comparing Drug-Eluting Stents to Bare-Metal Stents for Saphenous Vein Graft Lesion PCI.
Banerjee S; Brilakis ES
J Invasive Cardiol; 2016 Dec; 28(12):E170-E171. PubMed ID: 27922807
[No Abstract] [Full Text] [Related]
2. Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis.
Mosleh W; Gandhi S; Elsiddig M; Schwalm JD; Farkouh ME
J Invasive Cardiol; 2016 Dec; 28(12):E139-E169. PubMed ID: 27845875
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial.
Fahrni G; Farah A; Engstrøm T; Galatius S; Eberli F; Rickenbacher P; Conen D; Mueller C; Pfister O; Twerenbold R; Coslovsky M; Cattaneo M; Kaiser C; Mangner N; Schuler G; Pfisterer M; Möbius-Winkler S; Jeger RV;
J Am Heart Assoc; 2020 Oct; 9(20):e017434. PubMed ID: 33032485
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.
Mehilli J; Pache J; Abdel-Wahab M; Schulz S; Byrne RA; Tiroch K; Hausleiter J; Seyfarth M; Ott I; Ibrahim T; Fusaro M; Laugwitz KL; Massberg S; Neumann FJ; Richardt G; Schömig A; Kastrati A;
Lancet; 2011 Sep; 378(9796):1071-8. PubMed ID: 21872918
[TBL] [Abstract][Full Text] [Related]
5. Non-ST-segment elevation myocardial infarction related to vulnerable neoatheroma in bare-metal stents 2 years after percutaneous coronary intervention of a coronary saphenous vein graft.
Roleder T; Wańha W; Smolka G; Ochała A; Wojakowski W
JACC Cardiovasc Interv; 2014 Aug; 7(8):e95-6. PubMed ID: 25086848
[No Abstract] [Full Text] [Related]
6. Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions.
Ybarra LF; Ribeiro HB; Pozetti AH; Campos CA; Esper RB; Lemos PA; Lopes AC; Kalil-Filho R; Ellis SG; Ribeiro EE
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E856-63. PubMed ID: 23239630
[TBL] [Abstract][Full Text] [Related]
7. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
[TBL] [Abstract][Full Text] [Related]
9. Different vascular responses within the same stent detected by optical coherence tomography.
Samy B; Soeda T; Januzzi JL; Gaggin HK; Jang IK
Coron Artery Dis; 2014 Aug; 25(5):450-1. PubMed ID: 24842613
[No Abstract] [Full Text] [Related]
10. Drug-eluting versus bare-metal stents for saphenous vein graft lesions.
Conte SM; Florisson DS; De Bono JA; Vale PR
Intern Med J; 2019 Dec; 49(12):1534-1537. PubMed ID: 31808253
[TBL] [Abstract][Full Text] [Related]
11. Excimer laser for a highly stenotic saphenous vein graft: evidence of debulking by optical coherence tomography.
Niccoli G; Di Vito L; Montone RA; Porto I; Crea F
EuroIntervention; 2014; 9(12):1484. PubMed ID: 23838358
[No Abstract] [Full Text] [Related]
12. Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial.
Sosa A; Chao H; Guerra A; Han H; Christopoulos G; Christakopoulos GE; Tarar MN; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Banerjee S; Brilakis ES
Int J Cardiol; 2015; 186():261-3. PubMed ID: 25828130
[No Abstract] [Full Text] [Related]
13. Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts.
Taniwaki M; Räber L; Magro M; Kalesan B; Onuma Y; Stefanini GG; van Domburg RT; Moschovitis A; Meier B; Jüni P; Serruys PW; Windecker S
EuroIntervention; 2014; 9(12):1432-40. PubMed ID: 24064377
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of lesion-specific outcomes comparing drug-eluting stents and bare metal stents in diseased saphenous vein grafts.
Runyan D; Gorges R; Feldman D; McCullough PA; David S; Saba S
Rev Cardiovasc Med; 2013; 14(1):1-6. PubMed ID: 23651982
[TBL] [Abstract][Full Text] [Related]
15. A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis.
Mamas MA; Foley J; Nair S; Wiper A; Clarke B; El-Omar M; Fraser DG; Khattar R; Neyses L; Fath-Ordoubadi F
J Interv Cardiol; 2011 Apr; 24(2):172-80. PubMed ID: 21281356
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesions.
Pokala NR; Menon RV; Patel SM; Christopoulos G; Christakopoulos GE; Kotsia AP; Rangan BV; Roesle M; Abdullah S; Grodin J; Kumbhani DJ; Hastings J; Banerjee S; Brilakis ES
Catheter Cardiovasc Interv; 2016 Jan; 87(1):34-40. PubMed ID: 26033073
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.
Aggarwal V; Stanislawski MA; Maddox TM; Nallamothu BK; Grunwald G; Adams JC; Ho PM; Rao SV; Casserly IP; Rumsfeld JS; Brilakis ES; Tsai TT
J Am Coll Cardiol; 2014 Oct; 64(17):1825-36. PubMed ID: 25443706
[TBL] [Abstract][Full Text] [Related]
18. Update on Cardiac Catheterization in Patients With Prior Coronary Artery Bypass Graft Surgery.
Xenogiannis I; Tajti P; Hall AB; Alaswad K; Rinfret S; Nicholson W; Karmpaliotis D; Mashayekhi K; Furkalo S; Cavalcante JL; Burke MN; Brilakis ES
JACC Cardiovasc Interv; 2019 Sep; 12(17):1635-1649. PubMed ID: 31422085
[TBL] [Abstract][Full Text] [Related]
19. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
Rodés-Cabau J; Jolly SS; Cairns J; Mansour S; L'Allier PL; Teefy PJ; Graham JJ; Le May MR; Cantor WJ; Wood D; Balasubramanian K; DeLarochellière R; Dzavik V;
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27815344
[TBL] [Abstract][Full Text] [Related]
20. Vessel diameter should be taken into account in saphenous stenting.
Lozano I; Rondan J; Avanzas P
EuroIntervention; 2010 Apr; 5(8):991-3. PubMed ID: 20542787
[No Abstract] [Full Text] [Related]
[Next] [New Search]
